Bone Metabolism Tests Market Size, Share, and Trends 2024 to 2034

The global bone metabolism tests market size is calculated at USD 3.13 billion in 2025 and is forecasted to reach around USD 6.02 billion by 2034, accelerating at a CAGR of 7.53% from 2025 to 2034. The North America market size surpassed USD 1.13 billion in 2024 and is expanding at a CAGR of 7.73% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 5613
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Bone Metabolism Tests Market 

5.1. COVID-19 Landscape: Bone Metabolism Tests Industry Impact

5.2. COVID-19  Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Bone Metabolism Tests Market, By Product

8.1. Bone Metabolism Tests Market, by Product

8.1.1. Assay or Consumables

8.1.1.1. Market Revenue and Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Bone Metabolism Tests Market, By Technology

9.1. Bone Metabolism Tests Market, by Technology

9.1.1. Clinical Laboratory Improvement Amendments (CLIA)

9.1.1.1. Market Revenue and Forecast

9.1.2. Enzyme-linked immunosorbent assay (ELISA)

9.1.2.1. Market Revenue and Forecast

9.1.3. Other tests

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Bone Metabolism Tests Market, By Application 

10.1. Bone Metabolism Tests Market, by Application

10.1.1. Vitamin D Testing

10.1.1.1. Market Revenue and Forecast

10.1.2. Bone Metabolism

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Bone Metabolism Tests Market, By End User 

11.1. Bone Metabolism Tests Market, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast

11.1.2. Clinics

11.1.2.1. Market Revenue and Forecast

11.1.3. Laboratory Diagnostics

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Bone Metabolism Tests Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End User

Chapter 13. Company Profiles

13.1. F. Hoffmann-La Roche AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Abbott Laboratories  

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthineers

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Bio-Rad Laboratories, Inc.  

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Ortho Clinical Diagnostics  

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. DiaSorin S.p.A.  

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)  

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Quidel Corporation  

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global bone metabolism tests market size is expected to grow from USD 2.91 billion in 2024 to USD 6.02 billion by 2034.

The bone metabolism tests market is anticipated to grow at a CAGR of 7.53% between 2025 and 2034.

The major players operating in the bone metabolism tests market are F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A., Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), Quidel Corporation, and Others..

The driving factors of the bone metabolism tests market are the increasing demand for more efficient and sustainable solutions across various industries, changing consumer preferences, and rising technological advancements are expected to drive market growth.

North America region will lead the global bone metabolism tests market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client